AbbVie Investor Aims To Skunk $54B Shire Inversion
An AbbVie Inc. shareholder launched a putative class action Monday aimed at stopping the U.S. drugmaker's planned $54 billion takeover of European rival Shire PLC, claiming the inversion deal designed to...To view the full article, register now.
Already a subscriber? Click here to view full article